These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12954793)

  • 41. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide.
    Kiberd BA; Young ID
    J Lab Clin Med; 1994 Oct; 124(4):496-506. PubMed ID: 7930875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Augmentation of osteopontin expression in renal tubuli is independent of a histopathological type of glomerular lesions in mouse lupus nephritis.
    Sasaki Y; Yamamoto Y; Miyazaki T; Ito MR; Nose M; Watanabe M
    Pathol Int; 2006 Mar; 56(3):135-43. PubMed ID: 16497246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
    Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
    J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
    Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
    Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice.
    Hong Y; Wang T; Huang C; Cheng W; Lin B
    Lupus; 2008 Sep; 17(9):814-21. PubMed ID: 18755863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
    Ye M; Wysocki J; William J; Soler MJ; Cokic I; Batlle D
    J Am Soc Nephrol; 2006 Nov; 17(11):3067-75. PubMed ID: 17021266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice.
    Nozaki Y; Kitching AR; Akiba H; Yagita H; Kinoshita K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1210-21. PubMed ID: 24623145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.
    Racz Z; Nagy E; Rosivall L; Szebeni J; Hamar P
    Lupus; 2010 Apr; 19(5):599-612. PubMed ID: 20167630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
    Bagi Z; Hamar P; Kardos M; Koller A
    Lupus; 2006; 15(6):326-34. PubMed ID: 16830878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
    Reilly CM; Mishra N; Miller JM; Joshi D; Ruiz P; Richon VM; Marks PA; Gilkeson GS
    J Immunol; 2004 Sep; 173(6):4171-8. PubMed ID: 15356168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Image analysis for intercellular adhesion molecule-1 expression in MRI/lpr mice: effects of Chinese herb medicine].
    Chen X; Yu L; Lu Y
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):204-6, 253-4. PubMed ID: 7788548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury.
    Gelberg H; Healy L; Whiteley H; Miller LA; Vimr E
    Lab Invest; 1996 May; 74(5):907-20. PubMed ID: 8642786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of mesangial injury in glomerular diseases.
    Daha MR
    J Nephrol; 2000; 13 Suppl 3():S89-95. PubMed ID: 11132039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.
    Suganami T; Mukoyama M; Sugawara A; Mori K; Nagae T; Kasahara M; Yahata K; Makino H; Fujinaga Y; Ogawa Y; Tanaka I; Nakao K
    J Am Soc Nephrol; 2001 Dec; 12(12):2652-2663. PubMed ID: 11729234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron status alters murine systemic lupus erythematosus.
    Leiter LM; Reuhl KR; Racis SP; Sherman AR
    J Nutr; 1995 Mar; 125(3):474-84. PubMed ID: 7876923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.
    Kim JM; Wu H; Green G; Winkler CA; Kopp JB; Miner JH; Unanue ER; Shaw AS
    Science; 2003 May; 300(5623):1298-300. PubMed ID: 12764198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin.
    Zhao Z; Deocharan B; Scherer PE; Ozelius LJ; Putterman C
    J Immunol; 2006 Jun; 176(12):7704-14. PubMed ID: 16751418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice.
    Mühlfeld AS; Spencer MW; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Kidney Int; 2004 Oct; 66(4):1393-402. PubMed ID: 15458432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice.
    Herlitz H; Tarkowski A; Svalander C; Volkmann R; Westberg G
    Int Arch Allergy Appl Immunol; 1988; 85(3):272-7. PubMed ID: 3280501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.